|
Real-time Estimate
Cboe BZX
18:17:51 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.6260 USD | -28.85% |
|
+26.98% | -91.07% |
| 08-31 | Karyopharm Therapeutics Submits Supplemental New Drug Application to the Fda for Xpovio Plus Ruxolitinib for Patients with Myelofibrosis | CI |
| 08-29 | Karyopharm Therapeutics Inc. - Special Call |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KPTI | Delayed | |
CBOE
| KPTI | Real-time | |
|
Tradegate
| 25K0 | Real-time | |
|
Deutsche Boerse AG
| 25K0 | Delayed | |
|
Börse Stuttgart
| 25K0 | Delayed | |
|
Boerse Muenchen
| 25K0 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 1.88 | 1.88 | 1.88 |
| Spread/Res. | -65.05% | -65.05% | -65.05% |
| Spread/Supp. | +108.60% | +108.60% | +68.44% |
| Support | 0.315 | 0.315 | 0.3901 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KPTI Stock
- Charts Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
